We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Refine your search

Content type



3 results found


Smart & Biggar/Fetherstonhaugh | Canada | 31 Jul 2018

Rx IP Update - July 2018

As previously reported (here and here), the Patented Medicine Prices Review Board (PMPRB) has been consulting on its proposed reform of the federal

Previous page 1 Next page